SUMMARISED AUDITED ANNUAL RESULTS
FOR THE YEAR ENDED 30 JUNE 2024
| % change |
Year ended 30 June 2024 R’000 |
Restated* Year ended 30 June 2023 R’000 |
|
|---|---|---|---|
| Healthcare services revenue | 6.0 | 4 639 131 | 4 378 300 |
| Healthcare services operating costs | 7.2 | (4 038 306) | (3 766 970) |
| IFRS 16: Lease reversals | 78 872 | 75 241 | |
| Healthcare services operating profit | (1.0) | 679 697 | 686 571 |
| Healthcare retail revenue | (4.8) | 4 251 575 | 4 464 341 |
| Healthcare retail cost of sales | (6.1) | (3 370 496) | (3 590 850) |
| Healthcare retail operating costs | (1.0) | (670 433) | (677 168) |
| Healthcare retail operating profit | 7.3 | 210 646 | 196 323 |
| Total healthcare operating profit | 0.8 | 890 343 | 882 894 |
| Loss on sale of investment | (5) | — | |
| Fair value gains | 1 769 | 3 669 | |
| Other income | 5 186 | 2 570 | |
| Impairment of assets and loans | (274 265) | (27 115) | |
| Scrapping of intangible assets | (6 060) | (5 415) | |
| Net finance and investment income | (58 227) | (68 252) | |
| – Finance and investment income | 38 008 | 25 941 | |
| – Finance costs: Lease liabilities | (19 190) | (16 964) | |
| – Finance costs | (77 045) | (77 229) | |
| Share-based payment expense | (3 133) | (17 837) | |
| Share of (losses)/profits from associates and joint ventures | (9 045) | 14 051 | |
| Profit before depreciation and amortisation | (30.3) | 546 563 | 784 565 |
| Depreciation | (13.5) | (94 142) | (82 976) |
| Right of use assets depreciation | 19.3 | (52 747) | (65 380) |
| Amortisation of intangible assets | 7.7 | (192 690) | (208 823) |
| Profit before taxation | (51.6) | 206 984 | 427 386 |
| Income tax expense | 0.8 | (132 729) | (131 654) |
| Profit for the year from continuing operations | (74.9) | 74 255 | 295 732 |
| Loss on disposal of subsidiary | — | (198) | |
| Profit for the year | (74.9) | 74 255 | 295 534 |
| Other comprehensive (loss)/income | (9 433) | 8 684 | |
| Comprehensive net income for the year | (78.7) | 64 822 | 304 218 |
| Attributable to: | |||
| Equity holders of the Parent | 45 948 | 192 207 | |
| Non-controlling interest | 18 874 | 112 011 | |
| 64 822 | 304 218 | ||
| * | Refer to Note 5 for details of the restatement. |